A11932 | Pages: NA | Sep 2022 | 407 Views | ||
Author(s) : Onkar Sumant | Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the High Throughput Process Development Market
Request Now !High-throughput process development (HTPD) shortens development time and increases the amount of information available for quality by design (QbD) approaches. HTPD involves chromatography techniques, which help in better and accurate result prediction and analysis. High throughput process development addresses the concerns regarding the reduction of development time and enhancing the effectiveness of the final product by utilizing core knowledge. Furthermore, usefulness of high throughout tools in performing parallel screening of chromatography issues and media while saving enough time for process developers is boosting this market considerably
Market Scope and Structure Analysis
Report Metric | Details |
Market Size Available for Years |  2020–2028 |
 Base Year Considered |  2020 |
 Forecast Period |  2021–2028 |
 Forecast Unit |  Value (USD) |
 Segments Covered |  Product ,Type, Application, and Region |
 Regions Covered |  North America, Europe, Asia-Pacific, and LAMEA |
 Companies Covered | GE Healthcare, Danaher Corporation, Thermo Fisher Scientific Inc., Agilent Technologies, Merck Millipore ,Eppendorf , Bio-Rad Laboratories ,Perkinelmer, Sartorius Stedim Biotech, and Tecan Group |
Â
COVID-19 Impact Analysis
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the high throughput process development market.
Top Impacting Factors
Market Trends
New Product Launches to Flourish the Market
In March 2018, Sartorius Stedim Biotech launched the Ambr 250 high throughput perfusion, a new automated parallel bioreactor system. It has been specially designed for rapid cell culture perfusion process development to optimize production of therapeutic antibodies.
In April 2021, Thermo Fisher Scientific received authorization from the U.S. Food and Drug Administration for high-throughput and automated COVID-19 Test Kit.
Surge in Usage in R&D for Drug Discovery
Increase in R&D spending, technological advancements in process development, development of the biopharmaceutical industry, increase in demand for technical instruments to improve the quality of biological materials production, and increase in pressure to lower the cost of manufacturing are some factors which upsurge the market growth.
Key Segments Covered
Segment | Subsegment |
 Product Type |
|
 Technology |
|
 Molecule type |
Â
 |
 End User |
|
 Region |
|
Â
Key Benefits of the Report
Questions Answered in the High-throughput Process Development Market Report
Key Market Segments & Key Market Players
Segments | Sub-segments |
---|---|
By Product Type |
|
By Technology |
|
By Molecule type |
|
By End User |
|
By Region |
|
Key Market Players | GE Healthcare, Danaher Corporation, Thermo Fisher Scientific Inc., Agilent Technologies, Merck Millipore, Eppendorf, Bio-Rad Laboratories, Perkinelmer, Sartorius Stedim Biotech, Tecan Group |
Loading Table Of Content...
Start reading.
This Report and over 13,000+ more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
15%
Discount
15%
Discount
Enterprise
License/PDF
20%
Discount
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers